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Abstract
In addition to smoking and UV exposure, lifestyle factors such as diet, nutrition and physical activity, 
have been shown to play a significant role for many cancers. It is estimated that up to 50% of some 
cancer types are preventable; many through lifestyle and dietary changes with the presence or 
absence of certain dietary components strongly associated with an increased or decreased risk. Here 
we summarise the work that has been performed with polyphenols, with a focus on those derived 
from black raspberries.  These have been extensively studied for the prevention and treatment of a 
variety of conditions and diseases. Here we focus on their use for the prevention or treatment of 
specific cancer types and the impact they have on biological systems.  The aim is to highlight the need 
to improve our understanding of how the environment impacts upon the normal biological processes 
that affect health and disease, thereby, enabling us to implement smarter prevention and treatment 
measures.
1. Introduction
The global increase in the incidence and mortality of all cancer types is leading to an escalating burden 
on global economics and healthcare[1]. The reasons behind this are somewhat complex, but reflect a 
rapid population growth, an increased ageing population and alterations to the prevalence and 
distribution of risk factors attributed to the disease[1]. Lifestyle factors, such as diet, obesity, and 
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socioeconomic status have a profound impact on cancer incidence. Combined, these highlight an 
increasing demand for strategies for cancer prevention, as there is substantive evidence that diet, 
nutrition and physical activity play fundamental roles in cancer and disease prevention[2]. Over the 
last two decades, a substantial amount of research has focused on the chemopreventative and anti-
tumourigenic properties of dietary polyphenols, such as those found in many fruits and vegetables. In 
this review we will present the current position on lifestyle factors and cancer, the utilization of 
polyphenols by the body, summarise the data on polyphenols and specific tumour types, and how 
they influence the epigenome, microbiome and immunity.
1.1 Established causes of cancer 
There are over 100 different types of cancer, which is complicated further by the several sub-
classifications within each cancer[2]. Although the exact mechanisms and behaviours behind each 
cancer is not currently understood, the complex relationship between cancer, host, nutrition and 
physical activity are being explored. At a molecular level cancer arises from an accumulation of DNA 
damage and as a result of abnormal and uncontrollable cell division. There are several factors 
identified under the classic ‘hallmarks’ that can compromise normal cell division[3, 4], these can be 
broadly divided into two groups; ‘endogenous’ and ‘exogenous’ factors[2, 3], Figure 1.
1.2 ‘Endogenous’ Factors
Endogenous factors arise from processes within the individual. Less than 10% of cancers are attributed 
to inherited genetic mutations often affecting a tumour suppressor gene, for example, patients with 
familial adenomatous polyposis (FAP), inherit a mutated Adenomatosis polyposis coli (APC) gene and 
are predisposed to colorectal cancer (CRC)[5]. Other endogenous factors include imbalances in 
hormonal and metabolic pathways, chronic inflammation associated with DNA damage through 
genetic and epigenetic modifications and oxidative stress[3]. 
1.3 ‘Exogenous’ Factors
Exogenous factors are commonly termed as lifestyle factors. These include, carcinogens from smoking, 
excessive alcohol consumption, infectious agents: such as liver cancer from hepatitis B and C infections 
and Helicobacter pylori a cause of stomach cancer[2]; ionizing radiation from ultraviolet (UV) light and 
influences from nutrition, body fatness and physical activity[2]. The relationship between diet or 
physical activity and cancer are specific for certain cancers, such as the relationship between CRC and 
diets consisting of red and processed meats[6]. However, it is often the case that several exogenous 
exposures relating to diet and physical activity, are attributed to numerous cancer types[2]. 
In the UK around 4 in 10 cancer cases a year are linked to exogenous factors. The largest single 
cause of cancer is smoking, the predominant cause of lung cancer. Body fatness and obesity are 
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estimated to contribute to 6.3% of cancer cases. UV radiation and occupational risks make up 3.8% of 
UK cancer cases. Dietary factors have significant roles in the aetiology of many cancers, particularly 
CRC, excessive alcohol consumption, insufficient fibre intake and infections are attributable to 2-4% 
of cases[7]. To fully understand the chemopreventative mechanisms underpinning nutritional factors 
in cancer, both large-scale epidemiological and preclinical studies are necessary. One area of intense 
research has focused on the protective role of bioactive phytochemicals, in particular polyphenols.
1.4 Dietary polyphenols
Polyphenols are naturally occurring compounds enriched in fruits, vegetables and cereals and are a 
major source of antioxidants in the human diet. They are secondary metabolites in plants that aid in 
protecting against UV radiation and aggression by pathogens[8]. For many years plant-derived 
nutritional polyphenols have been investigated for their anti-tumourigenic[9] properties, protection 
against cardiovascular disease, diabetes, neurodegenerative disease[10], anti-inflammatory[11], anti-
thrombotic[12], and anti-viral[13] properties.
These antioxidants prevent damage to cells by scavenging and neutralising free radicals and 
reactive oxygen species (ROS) thereby reducing oxidative stress. Although ROS are naturally produced 
within the body from normal oxidative metabolism[14], accumulation of these species can be 
detrimental. High concentrations of free radicals and ROS can result in extensive DNA, membrane lipid 
and protein damage which can potentiate the development of cancer[14]. Naturally produced 
endogenous antioxidants remove free radicals and prevent cellular damage in the body. However, the 
body heavily relies on exogenous sources of antioxidants, mainly from the diet[15]. The most 
abundant antioxidants in our food are the polyphenols.
Based upon their chemical structure, nutritional polyphenols can be divided into several 
groups: the flavonoids, phenolic acids, stilbenes and lignans[12, 16]. The flavonoids can be further 
divided into six subgroups, flavonols, flavones, isoflavones, flavanones, anthocyanidins and flavanols 
(catechins and proanthocyanidins). 
1.5 Anthocyanins
The most abundant flavonoid found in fruit and vegetables are the anthocyanins. Anthocyanins are 
responsible for the variety of colours, most notably red, blue, purple and black, in the fruits, flowers, 
leaves, stems, and roots of plants[17]. Their bright colours attract animals and insects, aiding 
pollination and seed dispersal of plants. Additionally, their antioxidant properties defend against 
extreme UV exposure, pathogens and oxidative stress[18]. In humans, their antioxidant, anti-
carcinogenic and anti-inflammatory properties[19] have been widely investigated as a potential 
treatment for many cancers. 
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In the USA the estimated daily intake of anthocyanins is around 180 - 215 mg, approximately 
nine-fold more than other dietary flavonoids which are consumed at about 23 mg/ day[17]. These 
natural anthocyanins are well represented in our diet as they occur in red, blue and purple produce 
such as carrots, onions, aubergines, and grapes but they are most abundant in berry fruits (Table 1) 
[12, 20], having as high as 1480 mg of anthocyanin/ 100 g fresh weight berry[21]. The concentration 
of anthocyanins in fruits is dependent on the cultivator, growing conditions (e.g. amount and quality 
of sunlight, soil composition, salinity and temperature) and season[22]. There have been over 400 
different anthocyanins identified, but the 6 most common anthocyanidins (the sugar-free 
counterparts of anthocyanins) are pelargonidin, cyanidin, delphinidin, peonidin, petunidin, and 
malvidin, with cyanidin being the most abundant in nature. One berry known for its particularly high 
anthocyanin content is the black raspberry (BRB) (approximately 607 mg/ 100 g fresh weight) (Table 
1). Studies have indicated that BRB anthocyanins have chemoprotective roles[23, 24] and thus may 
have a potential use as a chemopreventative strategy against cancer. The main anthocyanins in BRBS 
are cyanidin-3-glucoside, cyanidin-3-sambubioside, cyanidin-3-xylosylrutinoside, cyanidin-3-
rutinoside and pelargonidin-3-rutinoside[25].
Berry Type Scientific Name Anthocyanin Content (mg/ 100g FW) Reference
Black chokeberry Aronia melanocarpa 307 ~ 1480 [21, 26]
Elderberry Sambucus nigra 332 ~ 1374 [21, 27]
Bilberry Vaccinium myrtillus 300 ~ 808 [27, 28, 29]
Black raspberry Rubus occidentalis 145 ~ 607 [30, 31]
Blueberry Vaccinium corymbosum 63 ~ 430 [28, 29, 31, 32]
Cranberry Vaccinium macrocarpon 19 ~ 360 [28, 29, 31, 32]
Evergreen blackberry Rubus laciniatus 91 ~ 164 [29, 33, 34]
Marionberry Rubus ursinus 62 ~ 200 [33, 34, 35]
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Red raspberry Rubus idaeus 28 ~ 104 [29, 30, 31, 32]
Strawberry Fragaria x ananassa 13 ~ 55 [29, 32, 36]
Anthocyanin content (mg/ 100 g fresh weight (FW)) in selected berries.
Table 1: Anthocyanin content in edible berry fruits
Range of anthocyanin content found in several berry fruits.
1.6 Anthocyanin Metabolism
Anthocyanins have poor bioavailability, often with as little as 0.1% of the ingested amount being 
detectable in urine[37], but berry metabolites can be detected in urine, faeces, blood and tissues. It is 
not fully understood why anthocyanins have a low bioavailability and thus this could be seen as a 
major limitation to the potential efficacy of berry chemopreventative interventions outside of the 
gastrointestinal tract. However, as ~60% of ingested anthocyanins reach the colon and come into 
direct contact with the gastrointestinal epithelium it may explain why berries have higher protective 
roles against gastrointestinal cancers[38]. Anthocyanin metabolism occurs within three distinct 
regions of the gastrointestinal tract, the stomach, the small intestine and the colon. These regions are 
distinct from one another due to varying pH and microbial diversities. Anthocyanins are most stable 
in the stomach due to a low pH (pH 1-2), and it is here intact anthocyanins are absorbed into the 
circulatory system. Most anthocyanins survive intestinal transit where they eventually get 
metabolised by the colonic microflora into a plethora of phenolic acids and other degradative products 
before being absorbed into the circulatory system. Anthocyanins can be sub-classified into sugar-free 
anthocyanidin aglycones and anthocyanin glycosides. The intestinal microflora hydrolyse the sugar 
moieties (glycosides) attached to anthocyanins, the higher pH (neutral) in the colon aids in the 
metabolism of anthocyanin aglycones to phenolic acids[37, 38] (Figure 2).
1.7 Black Raspberries
The black raspberry (Rubus occidentalis) is a minor but speciality fruit of eastern North America and 
shares its name with its western North American relative Rubus leucodermis. BRBs contain a range of 
nutrients and bioactive phytochemicals such as vitamin A, C, and E, folic acid, calcium, selenium, 
β-sitosterol, fibre, a variety of polyphenols such as ellagic acid, ferulic acid, ellagitannins, most 
abundantly anthocyanins, and other bioflavonoids[39]. Due to their expansive health benefits and 
protective properties against many human diseases and cancer, BRBs have been the most studied 
berry[38]. The chemopreventative properties of BRBs, in particular, their anthocyanin counterparts 
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have been investigated in vitro and in vivo in both human and animal models[24] with the best 
documented studies being for oral, oesophageal and colon cancers[40].
1.8 Chemopreventive Studies of Black Raspberries
1.8.1 Chemopreventive Studies of Black Raspberries in Oral Cancer
Oral cancer is the most common type of head and neck cancer and in 90% of cases it presents as a 
squamous cell carcinoma (SCC)[41] with strong evidence linking it to exogenous factors such as 
smoking and excessive alcohol consumption[41-43]. In 2006, a study investigated the effects of freeze-
dried BRB ethanol extracts at varying concentrations on cell lines derived from human SCC. The results 
indicated that the BRB extract had anti-proliferative effects in a dose-dependent manner and could 
induce apoptosis, terminal differentiation and suppress the translation of VEGF (vascular endothelial 
growth factor; potentially inhibiting angiogenesis which would aid tumour development)[44]. 
In a clinical study with oral intraepithelial neoplasia (IEN), a precursor of oral SCC, topical 
application of a 10% freeze-dried BRB mucoadhesive gel was administered (0.5g) to the tongue four 
times a day for 6 weeks. The study reported that the lesion grade decreased in 41% of patients, while 
23% of patients had an increase in lesion grade and 35% of participants remained at a stable state. 
Importantly, the study concluded that freeze-dried BRB gel was safe to use as patients enrolled in the 
clinical trial reported no BRB gel associated toxicities[45]. The BRB-induced reduction in size and grade 
of oral IEN lesions may in part, be attributed to increased levels of pro-apoptotic and terminal 
differentiation genes, reduced epithelial levels of the pro-inflammatory proteins cyclooxygenase-2 
(COX-2) and inducible nitric oxide synthase (iNOS).  However, the study reported significant 
interpatient variation[46]. 
The success of these studies led to the development of a multi-centred placebo-controlled 
trial, investigating the efficacy of the BRB gel over a 3-month period. The previously described dosing 
regime was utilised in patients with confirmed oral IEN. Compared to placebo treated patients, BRB 
gel intervention resulted in significant reductions in both lesion size and grade[47]. In a more recent 
clinical trial, oral cancer patients were treated with dissolvable slow-release BRB troches which 
equated to a daily dose of 4.3g freeze-dried BRB powder. Treatment with these BRB troches resulted 
in the reduction of pro-inflammatory and pro-survival genes and reduced biomarker expression of 
genes dysregulated in oral cancers[48].
Since these clinical trials, substantial work has focused on the development of suitable in vivo 
animal models that better represent carcinogen induced oral dysplasia’s in humans, such that the 
chemopreventative mechanisms of BRBs could be further investigated. In 2012, a novel non-surgical 
murine model of oral cancer was developed, whereby animals were exposed to an environmental 
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pollutant and component of tobacco smoke dibenzo[a,l]pyrene, and its diol epoxide metabolite. 
Topical exposure of these carcinogens to the oral cavity of mice resulted in 74% and 100% OSCC in 
tongue and oral tissues respectively; mediated via the induction of DNA adducts, prerequisites for oral 
carcinogenesis[49 50]. These mice were fed either a control diet (AIN-93M) or a diet supplemented 
with 5% BRB powder for 2 weeks prior to the induction of tumourigenesis in the oral cavity. The study 
reported that administration of a 5% BRB diet prior to carcinogen exposures resulted in fewer DNA 
adducts and abrogated tumour incidence from 93% to 66%[51]. It was later reported that BRB-
mediated reduction in oral mutagenesis could be attributed, in part, to epigenetics and hyper-
methylation of genes involved in epithelial-mesenchymal transition (EMT)[52]. These BRB-mediated 
metabolomic effects in oral cancer are further supported in a study by Knobloch et al. (2019), using a 
chemically-induced model of oral cancer, (4-nitroquinoline-1-oxide)[41], whereby 6-week exposure to 
a 10% BRB diet inhibited enzymes fundamental for the metabolic pathway of glycolysis, thereby 
limiting nutrient availability for cancer cells[53].
1.8.2 Chemopreventive Studies of Black Raspberries in Oesophageal Cancer
Worldwide, oesophageal cancer ranks the 7th most common cancer[1]. Oesophageal cancers 
present as one of the two most common histological subtypes; SSC or adenocarcinoma and is linked 
to excessive alcohol consumption, tobacco carcinogens or drinking scalding hot mate (a plant-based 
infusion drunk in parts of South America), whereas adenocarcinomas are often attributed to higher 
socioeconomic countries where obesity and gastroesophageal reflux disease (GERD) are on the rise[2, 
54].
In 2001, in vivo studies using the NMBA (N-nitrosomethylbenzylamine) rat model of 
oesophageal cancer reported that feeding of 5 and 10% lyophilised BRB diet for 2 weeks prior to NMBA 
exposure and then throughout a 30 week time period, resulted in significant reduction in tumour 
multiplicity and inhibited the formation of mutagenic DNA adducts[55]. Additional studies with this 
model have reported that BRB diet reduced rat oesophageal cancer by decreasing DNA adducts 
(specifically O6-methylguanine), inhibiting proliferation and dampening down expression of pro-
inflammatory enzyme Cox-2[56], reversing oxidative stress[56, 57] and via inhibition of pro-
angiogenesis genes such as Vegf[58]. BRBs have also been shown to inhibit NMBA-induced 
oesophageal cancer by inhibiting the Wnt signalling pathway through alleviation of hypermethylation 
of the Wnt pathway antagonist, Sfrp4 (secreted frizzled related protein 4), and reduction in mRNA 
levels of DNA methyltransferases, Dnmt1 and Dnmt3b. These BRB-mediated alterations resulted in 
significant reductions in nuclear β-catenin localisation thus preventing proliferation of rat oesophageal 
squamous cell papilloma[59].
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In 2016, BRBs were used in a phase I pilot study in patients with Barrett’s esophagus (BE), a 
precursor lesion for oesophageal adenocarcinoma (EAC). To determine the long-term tolerability of 
BRBs in oesophageal cancer, a 6 month pilot study was performed. Based on rodent pre-clinical 
studies, patients confirmed to have BE were administered lyophilised or freeze-dried BRB powder at 
32 and 45g (~1.5 and 2 cups of whole fruit)[40, 55, 56, 60]. Results showed that lyophilised BRBs were 
generally well tolerated with a few adverse effects including epigastric pain, diarrhoea and 
constipation, and resulted in increased levels of GST-pi (a marker of detoxification) in over 50% of 
patients. Suggesting BRBs may help prevent BE progression by detoxification of the mutagenic 
components involved in gastroesophageal reflux disease[61, 62]. 
In addition, the chemopreventive properties of BRBs in oesophageal cancer have been linked 
in part to their effects on inflammation and immune cell trafficking. Exposure to 6.1% BRB diet, a BRB-
derived anthocyanin-enriched fraction (3.8 µmol/g) or treatment with protocatechuic acid, a major 
microbial-generated metabolite of BRB anthocyanins, inhibited NMBA-induced rat oesophageal 
cancer. Mechanistically, this was found to occur through inhibition of inflammatory genes Cox-2 and 
IL-1β, reduced infiltration of inflammatory macrophages into dysplastic lesions, limited neutrophil and 
cytokine accumulation and decreased angiogenesis[63, 64].
Similar results to both of these studies have been reported using human oesophageal 
microvascular endothelial cells (HEMEC) stimulated with either the pro-inflammatory cytokine tumour 
necrosis factor-alpha (TNF-α) or IL-1β. HEMEC cells were pre-treated with BRB ethanol extract for 2 
hours before activation with TNF-α or IL-1β. BRB ethanol extract had a strong anti-inflammatory effect 
by inhibiting NF-κΒ nuclear translocation, reducing COX-2 gene and protein levels in stimulated 
HEMECs, abolished the pro-angiogenic effects of VEGF by inhibiting cell migration, proliferation, and 
survival of VEGF-stimulated HEMECs[65]. 
1.8.3 Chemopreventive Studies of Black Raspberries in Colorectal Cancer
Colorectal cancer (CRC), which encompasses both colon and rectal tumours, is the third most common 
cancer in men (10% of total cancer cases) and the second most common cancer in women (9.2% of 
total cancer cases) worldwide[66]. In 2018 alone, it was estimated that there were more than 1.8 
million new CRC diagnoses and 881,000 deaths reported[1], highlighting the burden CRC puts on the 
healthcare infrastructure. CRC incidence displays wide geographical variation globally, with similar 
patterns seen for both men and women. CRC is often considered a marker of socioeconomic 
development since it mostly occurs in countries undergoing major development and nutritional 
transition and in those which have a high human development index[1, 2, 66].
The majority of CRCs are adenocarcinomas (approximately 95%) which occur sporadically, 
with only a small proportion of CRC cases attributable to inherited genetic mutations (~10%); mainly 
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FAP and Lynch Syndrome. There is evidence that CRC likely develops through an interplay of 
endogenous (epigenetic, microbial status, inflammation, immune status) and exogenous factors (diet 
composition, stress, alcohol consumption, smoking and obesity) which increase mutation rates[67]. In 
the UK alone it is estimated that around half of CRC cases could have been prevented through lifestyle 
modifications such as alteration to the diet and reduction in body fatness[2].The combination of 
damage from carcinogens that directly interact with the intestinal and colonic epithelium, and the 
mechanical deformation likely underpins the high rate of intestinal stem cell (ISC) division which is 
required to maintain an intact epithelial barrier. In turn this can lead to increased CRC risk due to a 
build-up of oncogenic DNA mutations in ISCs[68].
In 2001, a study investigated the protective effects of lyophilised BRBs in the azoxymethane 
(AOM) rat model of CRC[69]. AOM-induced rodent CRC, occurs via the production of DNA adducts 
following AOM metabolism, and faithfully models sporadic and hereditary human CRC development 
sharing similar genetics, histopathological characteristics and defective mismatch repair to the human 
disease[70]. Twenty-four hours after final treatment with AOM, rats were fed either 0%, 2.5%, 5% or 
10% freeze-dried BRB diet for 9 and 33 weeks. The total tumour multiplicity decreased by 42%, 45%, 
and 71% respectively, in a dose-dependent manner, tumour burden also decreased in a similar fashion 
but was not found to be significantly different. This demonstrates the ability of BRBs to reduce 
tumourigenesis in a rodent model of colon carcinogenesis[69].
In 2010, Bi and colleagues performed in vivo experiments in two genetic murine models of 
human CRC to investigate whether BRBs would inhibit tumourigenesis[71]. The two mouse models 
used were Apc1638+/-, which develops small intestinal tumours as a result of having only one 
functional allele of Apc with subsequent loss of the wild type allele leading to aberrant Wnt 
signalling[72] and the Muc2-/- mouse which develop spontaneous intestinal and colonic adenomas in 
response to chronic inflammation[73]. A 12-week feeding programme of 10% freeze-dried BRB diet 
significantly decreased tumour incidence and tumour multiplicity in Apc1638+/- mice by 45% and 60% 
respectively. Similarly, in Muc2-/- mice, feeding of BRBs reduced tumour incidence and multiplicity by 
50%. BRBs appeared to inhibit proliferation in both models, whereas terminal differentiation of goblet 
cells was not altered, potentially due to a relatively short feeding programme. Quantification of other 
cell types, such as enteroendocrine, Paneth and enterocytes may provide a better insight into the 
effects of BRBs on intestinal cell differentiation in the future. Mechanistically it was reported that 
reductions in tumourigenesis within the two models was via two different biological pathways. BRBs 
elicited anti-tumour effects in Apc1638+/- mice through inhibition of Wnt/β-catenin signalling and its 
downstream targets, including c-Myc and CyclinD1, whereas in the Muc2-/- mouse BRBs down-
regulated cytokines commonly associated with inflammation, including Cox-2, Tnf-α, IL-1, IL-6 and IL-
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10[71]. These models were the first to suggest potential mechanisms of action of BRBs against in vivo 
CRC development. 
The hereditary condition FAP is characterised by an early onset of colonic polyposis which 
confers an increased risk of developing CRC. A key phase Ib study was conducted to investigate the 
effects of BRBs on FAP patient rectal polyps[74]. Patients with at least 5, ≥2mm rectal polyps at 
baseline endoscopy were enrolled into the study and randomly divided into two groups consisting of 
7 patients each. Group 1 received placebo powder slurry (maltodextrin and dextrose) taken orally 3 
times a day (60 g/ day in total) and two BRB rectal suppositories at night (each containing 720 mg BRB 
powder). Group 2 received a BRB powder slurry 3 times a day (60 g/ day in total) plus two BRB rectal 
suppositories. BRB intervention was continued for up to 9 months. The study showed that, despite 3 
non-responders, BRB rectal suppositories were sufficient to reduce polyp burden and regress rectal 
polyps, but there was no added benefit from oral BRB powder consumption[74]. Within responding 
adenomas, BRB treatment decreased cellular proliferation, and positively impacted on epigenetic 
marks and proteins by decreasing promoter methylation, but had no effect on cell death[74]. These 
results suggest that BRBs may be a potential adjuvant treatment to improve the outcome for FAP 
patients.
1.8.3.1 Black raspberries and epigenetics 
Epigenetics refers to the study of the heritable and dynamic chemical modification of a cell’s 
transcriptional capacity, without any alteration to the genetic sequence[75]. Epigenetic mechanisms 
include but are not limited to histone modification, modulation of DNA methylation status and miRNA-
mediated manipulation of translation; these mechanisms regulate gene expression and can impact 
upon tumourigenesis. Several major enzymes that catalyse these mechanisms: DNA 
methyltransferases (DNMTs); ten eleven translocation (TET) enzymes; histone acetyltransferases 
(HATs) and histone deacetylases (HDACs)[75]. Metabolites resulting from processed dietary 
phytochemicals and fibre can affect these enzymes and epigenetic mechanisms, and ultimately gene 
expression. Specifically, in the context of cancer, genes involved in tumour suppression are usually 
hypermethylated resulting in epigenetic gene silencing; a mechanism that supports tumour 
survival[76].
Previous studies by Wang et al. have reported an association between BRB-derived 
anthocyanins and a decreased hypermethylation status seen in CRC, suggesting that BRBs could play 
a role in modulating epigenetic events[77]. Typically, promoter regions of Wnt pathway antagonists 
such as SFRP2, are hypermethylated in human CRC, leading to aberrant Wnt signalling and tumour 
progression. Human CRC cell lines treated with BRB-derived anthocyanins for three days at 0.5, 5, and 
25 μg/ml suppressed DNMT1 (maintenance DNA methyl transferase) and DNMT3b (de novo DNA 
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methyl transferase) activity. Additionally AC exposure resulted in the reactivation of Wnt pathway 
repressors, CDKN2A, SFRP2, SFRP55 and WIF1, via promoter demethylation. This resulted in the 
induction of apoptosis, cell cycle arrest and mRNA suppression of key Wnt regulators, β-catenin and 
C-MYC (a downstream target of the Wnt pathway), in these CRC cell lines[78].
The role of BRBs on epigenetic silencing has been evaluated in precancerous murine models 
that recapitulate human ulcerative colitis (UC, an intermediary step of colon carcinogenesis that is also 
influenced by deregulation of the Wnt pathway). IL-10 knockout UC mice fed a 5% BRB diet had less 
colonic ulceration as a result of reduced nuclear localisation of β-catenin than respective control 
mice[79]. This study also reported that mRNA expression of Wnt repressors was significantly 
upregulated in BRB treated mice, which coincided with hypomethylation of the same gene promoters 
and decreased protein levels of methylation-regulating proteins DNMT, HDACs and methyl-binging 
domain proteins (Mbd2), compared to control fed UC mice[79]. Studies from the same group using a 
dextran sodium sulfate (DSS)-induced, an irritant that induces extensive colonic mucosal 
inflammation, UC model reported that 5% BRB diet significantly reduced colonic ulceration and 
decreased protein levels of Dnmt3B, Hdac1, Hdac2 and Mbd2 and reduced promoter methylation of 
Wnt repressor genes[80]. In AOM(azoxymethane) /DSS chemically induced murine cancer models, 
diets containing 3.5 µmol/g and 7 µmol/g BRB-derived ACs, which corresponded to the AC 
concentrations in 5 and 10% freeze-dried BRB powder respectively, resulted in significant reduction in 
Dnmt1 protein expression.  However, BRB anthocyanins had no effect on TET enzyme mRNA 
expression (which mediate active DNA demethylation) in the intestinal epithelium at either 
concentration[81], this suggests that BRB-induced demethylation is a passive process in this context. 
Similarly, to other studies, the cancer preventative effect of BRBs was also linked to the promoter 
demethylation of Sfrp2, and subsequent increase in Sfrp2 protein concentration negatively regulating 
Wnt/β-catenin signalling[81].
In a phase 1 clinical study of 20 CRC patients who were treated with oral BRB powder (60 
g/day) for 1-9 weeks, epigenetic changes were only observed in patients who only received on average 
4 weeks of BRB intervention, with reduced promoter methylation of key Wnt pathway inhibitors and 
decreased expression of DNMT1[77]. Epigenetic changes were confirmed in a subsequent phase 1b 
clinical trial, in which 14 FAP patients received BRB intervention through rectal suppositories with or 
without the addition of oral supplementation for 9 months. Here the majority of patients (11/14) 
responded to the BRB treatment with polyp regression and significant decreases in protein levels of 
DNMT1 with reactivation of the silenced p16 promoter[74]. Providing direct clinical evidence for berry 
mediated chemoprevention. 
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Aside from BRB anthocyanins, the dietary fibre obtained from sources such as BRBs can also 
protect against tumourigenesis through several mechanisms. Firstly, increased speed of colonic transit 
helps minimise epithelial exposure to carcinogens and secondly, metabolism of fibre by gut bacteria, 
such as Anaerostipes or Clostridia, into short-chain fatty acids (SCFAs) such as butyrate, acetate and 
propionate, can cause tumour-influencing epigenetic alterations[82]. SCFAs are a source of energy but 
also act as signalling molecules within the body. Butyrate is the main source of energy for colonocytes 
and can also induce apoptosis in cancer cells[83]. Intracellular butyrate and propionate can inhibit gut 
HDAC activity, promoting hyperacetylation of histones (limiting methylation and thus reducing 
epigenetic silencing of anti-tumourigenic genes) and can impact on signal transduction[84]. H3 
acetylation in the promoter and conserved non-coding (CNS1) regions of the Foxp3 locus (which 
controls colonic T-regulatory cell population thought to be cancer preventative) is enhanced by 
butyrate-mediated HDAC inhibition[85]. Butyrate, along with propionate and acetate, activate free 
fatty acid receptor 2 (FFAR2), the receptor for short-chain fatty acids which regulates whole-body 
energy homeostasis and is an important regulator of inflammation involved in enhancing T-reg cell 
accumulation. Stimulation of FFAR2 via SCFAs is essential for innate immunity and chemoattractant-
induced responses; SCFA-mediated T-reg accumulation is important in limiting inflammatory 
responses associated with tumourigenesis[85, 86]. In disease states or conditions resulting from 
inadequate diets, such as CRC, the levels of SCFA may be diminished, which can mitigate the protective 
effects of SCFA-mediated immune regulation[87]. 
In more recent years there have been emerging roles of microRNAs (miRNAs, small noncoding 
RNAs) in epigenetic regulation. miRNAs can act as epigenetic regulators post-transcriptionally, altering 
target mRNAs and interfering with protein translation without modifying gene sequences. This is often 
via the induction of mRNA degradation or repression, physical interaction of miRNAs with RNA 
interference machinery[88]. In addition to being epigenetic regulators, miRNAs can themselves be 
regulated by the epigenetic machinery involved in DNA methylation and RNA and histone 
modifications. miRNAs have been implicated in several fundamental biological processes such as 
proliferation and migration. The impact of miRNAs on physiological and pathophysiological processes 
can be either beneficial or detrimental depending on the specific miRNA and its target, and 
dysregulation of this complex miRNA-epigenetic feedback loop can contribute to tumourigenesis[88]. 
Studies have shown that diet, and the subsequent downstream effects of dietary components on the 
microbiome and production of metabolites can influence and interact with miRNAs. miR-92a, a 
member of the miR-17-92a cluster important in regulating cell cycle, proliferation and apoptosis has 
been shown to be 7x higher in human CRC tissue compared to adjacent healthy tissue from the same 
patient[89]. miR-92a has been implicated in tumour development through its suppressive interaction 
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with the anti-apoptotic molecule, BCL-2-interacting mediator of cell death (BIM), in human CRC cell 
lines and colonic cancer tissue[90]. In human CRC cell lines, microbe-derived butyrate has been shown 
to reduce the levels of miR-92a and other miRNAs belonging to the miR-17-92a cluster. A cancer 
protective role of butyrate was identified via butyrate’s silencing effect on c-Myc protein levels leading 
to a reduction in c-Myc-induced miR-17-92a promoter activity and ultimately reducing levels of 
oncogenic miR-92a synthesis[89].  A recent study has identified a BRB-mediated chemopreventative 
association with miR-24-1-5p in CRC through inhibition of Wnt/B-catenin signalling and subsequent 
downstream targets involved in CRC tumourigenesis[91]. Utilising the colitis-induced CRC model 
(AOM/DSS), expression levels of miR-24-1-5p was found to be low in tissues from AOM/DSS-induced 
mice but was significantly increased in AOM/DSS mice following 9-week feeding intervention with BRB 
anthocyanins (7μmol/g BRB anthocyanins equating to a 10% BRB diet)[92]. It was shown that 
upregulation of miR-24-1-5p in human CRC cell lines leads to inhibition of cancer cell proliferation, 
migration and survival, by suppressing β-catenin protein levels and modulating downstream target 
gene expression[92]. FAP patients who responded to 9 month BRB suppository intervention had 37 
unique miRNAs that were demethylated in adenomas, whilst in these same patients promoter 
methylation of Wnt suppressors was not altered, indicating the uniquely demethylated miRNAs  
regulate the Wnt signalling pathway[74]. Together these studies highlight a potential mechanism 
whereby BRBs and their anthocyanin derivatives can mediate tumour suppression through miRNA 
epigenetic interaction with β-catenin and downstream Wnt target genes. We are yet to fully establish 
the chemopreventative relationship between BRBs and epigenetic gene regulation in the colon, 
however, there is increasing evidence suggesting that BRBs and their microbial-derived metabolites 
play roles in regulating the epigenome and can influence carcinogenesis. 
1.8.3.2 Black raspberries, microbiome and the metabolome
The microbiota of the human gut is a symbiotic web consisting of trillions of microorganisms: primarily 
bacteria, but also viruses, archaea, fungi and protozoa[93]. The human gut microbiome refers to the 
collective genomes of these microorganisms, in which there are approximately 3.3 million genes 
encoded[94]. The importance of the gut microbiota on human physiology has become increasingly 
apparent over the past decade. With the advent of ‘omic’ technologies and the rapidly developing 
analytical and sequencing techniques that follow we can now study the impact of the microbiota on 
health and disease in great detail.
The human microbiota is often referred to as a hidden organ, with its own physiology and 
pathophysiology[95]. It is essential in regulating normal gut homeostasis and health and is a relatively 
stable entity once it has been established. However, the microbiome can be manipulated and altered 
through intervention with antibiotics or changes in diet, resulting in dysbiosis and disease.  Dysbiosis 
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of the intestinal microbiota, contributes to many disease states including obesity, diabetes and 
inflammatory bowel disease, all of which may predispose to CRC[96, 97]. 
Excessive consumption of dietary elements such as protein, sugar and saturated fatty acids 
can adversely affect the gut microbiota, decreasing microbial diversity and resulting in inflammation 
and decreased production of butyrate[98]. Intake of fibre and polyphenols positively influence the 
microbiota, resulting in increased frequency of beneficial gut microbes that exert biological effects 
including reduced inflammation, increased antioxidant production and increased butyrate 
production[99]. BRBs, and the abundance of fibre and polyphenols such as anthocyanin and 
ellagitannin contained within them, are capable of altering the composition and metabolic potential 
of the gut microbiota[100]. A BRB diet has been shown to positively influence the ratio of beneficial 
gut microbes including those of the genera Anaerostipes, Akkermansia, Desulfovibrio and members of 
the phylum Bacteroidetes[99, 101]. 
Metabolomic studies have identified an enrichment in several beneficial metabolic pathways 
and metabolites, including butyrate, in mice fed a diet rich in BRB[98]. Rats fed a BRB diet showed an 
increase in butyrate-producing bacteria such as Anaerostipes when compared to a control diet[99]. It 
has been shown that FFAR2, the receptor for short-chain fatty acids, is required for the beneficial 
effects of BRBs; indicating bacterial fermentation is an important mechanism underpinning BRB-
mediated benefits[102]. Colonic inflammation and the subsequent cytokine and ROS generation 
results in an increase in opportunistic, adhesion-invasive bacterial species such as Escherichia coli that 
further promote inflammation, and a decrease in species from Akkermansia and Desulfovibrio genera 
that have anti-inflammatory effects[101]. Intervention with a BRB diet can reduce inflammation and 
the increased risk of tumourigenesis associated with it by increasing the abundance of these anti-
inflammatory bacterial species and via increased activity of FFAR2, which has been implicated in 
suppressing colonic inflammation. 
Several studies have demonstrated the association of an increased Firmicutes to Bacteroidetes 
ratio with diet-induced obesity[103]. Firmicutes are positively selected for in obesity as member 
species have an increased capacity for processing polysaccharides, a major component of diet-induced 
obesity[104]. Furthermore, it has been reported that obese individuals have a decreased population 
of Akkermansia muciniphila which, as previously stated, is a bacteria that has anti-inflammatory 
effects as well as anti-diabetic and anti-obesity functions, including roles in glucose homeostasis and 
adipose metabolism[101]. A BRB rich diet has been shown to modulate the murine gut microbiota, 
increasing the abundance of Bacteroidetes compared to Firmicutes and the abundance of A. 
muciniphila[101]. This microbial modulation via BRB intervention provides a number of bacterial 
metabolic alterations, including increased biosynthesis of vitamins and essential amino acids, that 
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provide health benefits to the host such as reduced inflammation and increased cardiac and neural 
tube protection[101, 105]. Regulating inflammation and helping to maintain a healthy weight are 
some of the key elements of BRB-mediated chemoprevention.
The phytochemicals contained within BRBs are processed and absorbed by the various 
microbes in the gut but the subsequent metabolites can be transported through the body and exert 
systemic beneficial effects. Metabolomic approaches have shown alteration in over one hundred 
metabolites across the colonic mucosa, liver and the faeces of healthy mice fed a BRB supplemented 
diet. BRB supplementation decreased certain lipid metabolites in the colon including long-chain fatty 
acids and omega-6 polyunsaturated fatty acids, which can contribute to insulin resistance, 
inflammation and obesity when consumed in excess. Conversely, BRBs led to an increase in cancer 
protective omega-3 polyunsaturated fatty acids (⍵-3 PUFA), such as linolenate, in the liver[106, 107]. 
Linolenate is converted to docosapentaenoate (DPA), docosahexaenoate (DHA) and 
eicosapentaenoate (EPA), each of which has been shown to provide metabolic, anti-inflammatory and 
neuroprotective benefits[108]. Clinical studies have also indicated an improvement in body weight 
and physical, cognitive and social functions in lung cancer patients given a daily supplement of DHA 
and EPA, further demonstrating how BRBs exert their chemoprotective effects[109]. 
Several species of bacteria that have generated interest due to their tumourigenic potential 
in the gastrointestinal tract, namely: Fusobacterium nucleatum, Escherichia coli and Bacteroides 
Fragilis. In both cell lines and patient-derived xenograft (PDX) murine models, the presence of F. 
nucleatum increases tumour cell proliferation and overall tumour growth rates[110]. E. coli that 
express the genomic island polyketide synthase can produce DNA alkylating genotoxins that may 
result in mutagenic DNA damage leading to tumourigenesis[111]. B. Fragilis, along with F. nucleatum 
and E. coli can create a tumourigenic biofilm that facilitates bacterial epithelial infiltration, recruits 
immune cells, and promotes inflammation in precancerous colonic lesions[112]. BRB intervention has 
been shown to increase the abundance of butyrate-producing bacteria; butyrate stimulates mucus 
production and maintains epithelial integrity, possibly protecting against the adverse effects resulting 
from biofilm generation[113].
As previously described, the microbiota has the capacity to influence many disease states in 
the gut. Pathobiotic bacteria, such as E. coli, which accumulate in a poor-diet or disease-state gut, can 
penetrate the gut epithelium and generate toxins that promote colonic inflammation and 
tumourigenesis[114]. Studies using mice have shown that in circumstances such as these, antibiotics 
can be used to suppress this pathobiotic accumulation, and ultimately, the adverse effects associated 
with it[115]. Conversely, the use of antibiotics can also reduce the frequency of beneficial gut microbes 
and depletion of the gut microbiota may encourage the growth of antibiotic-resistant bacteria that 
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can further induce inflammation[116]. The gut microbiota is essential in facilitating the beneficial 
effects of BRBs and any perturbation of the gut microbial content has the capacity to interfere with 
these effects. Administration of a 5% BRB diet to ApcMin/+ mice (which mimics FAP disease) did not 
effect polyp development in mice that had been treated with antibiotics (1 g/L ampicillin, 1 g/L 
neomycin, 1g/L metronidazole, and 0.5 g/L vancomycin in the drinking water)[102]. This demonstrates 
that the gut microbiota is indeed required for BRB-mediated chemoprevention. Homozygous deletion 
of Apc within the ISC compartment of mice, that recapitulates the initial stages of CRC initiation, has 
also been shown to alter the composition of the microbiota as seen with trends of increasing 
abundance of Bacteroides and Clostridium XVII[117] which can contribute to the tumourigenic biofilm. 
The gut microbiota is affected very early on in tumourigenesis and has the potential to serve as an 
early diagnostic tool. Mice fed a diet of 10% BRBs from 2-weeks prior to induction of ISC Apc loss have 
a reduced impact to the gut microbiota upon tumourigenesis, indicating that BRBs can abrogate the 
initial cancer-mediated alterations to the microbiota and promote a favourable Bacteroidetes to 
Firmicutes ratio which supports a leaner bodyweight[117]. Further work with larger sample sizes is 
needed to fully characterise the effect of BRBs on the composition and function of the microbiota in 
CRC.
1.8.3.3 Black raspberries, inflammation and immunity
Chronic inflammation is a major risk factor for CRC and is considered a hallmark of cancer[4]. 
Inflammation involves a complex network consisting of numerous immune and inflammatory cells, 
cytokines, chemokines and pro-inflammatory mediators[118]. Inflammation and subsequent 
accumulation of immune cells in inflammatory areas can lead to the activation of signalling pathways 
that promote tumour growth and invasion. Increased activation of inflammatory signalling pathways 
can often lead to genetic instability, an increased incidence of oncogenic mutations and result in 
inflammation-mediated carcinogenesis[119]. BRB intervention can help to reduce inflammatory-
mediated tumourigenesis through its inhibition of certain pro-inflammatory mediators and its 
regulation of immuno-modulatory cells[23, 24].
The pro-inflammatory mediator COX-2 is elevated in many cancers including CRC and can be 
rapidly and transiently induced by inflammatory cytokines and growth factors[120]. COX-2 is an 
enzyme responsible for the production of prostaglandins that enhance tumour growth and can aid in 
tumour evasion from the immune system by modulating the tumour microenvironment[121]. A 
further role of COX-2 in tumourigenesis is its capacity to increase tumour invasiveness and metastatic 
potential[122]. Several studies have demonstrated that BRB diet can suppress COX-2 expression 
through inhibition of the transcription factor, nuclear factor-κΒ (NF-κΒ), which is involved in signalling 
pathways (e.g. MAPK signalling), proliferation, cell adhesion and immune/inflammatory 
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modulation[123-125]. In murine macrophages stimulated by the endotoxin lipopolysaccharide (LPS), 
administration of an anthocyanin-rich BRB fraction reduced LPS-induced inflammation (by dampening 
iNOS expression) and through inhibition of the MAPK pathway[126]. More recently a unique 
phytochemical from berry fruits known as triterpenoid glycosides have been implicated in disease 
prevention. Specifically, oral administration of a triterpenoid-rich fraction (TFRC, 25, 50, or 100 
mg/kg/day) from the Korean black raspberry (Rubus coreanus) has been shown to ameliorate colitis 
in DSS-treated mice, maintaining crypt structures and reducing markers of inflammation including 
reductions in Tnf-α, IL-1β, and IL-6 mRNA levels. TFRC protected against colitis and in turn 
carcinogenesis by reducing macrophage accumulation in mice and inhibited nitric oxide and 
prostaglandin production by suppressing iNOS and Cox-2 levels, downstream inflammatory cytokines 
and members of the MAPK/NF-κB pathway in vitro[127]. Similarly, in DSS-induced colitis mice, a 5% 
BRB diet reduced macrophage and neutrophil accumulation and suppressed nuclear translocation of 
NF-κB[80].
Natural killer (NK) cells are a type of innate immune lymphocyte that exhibits cytotoxic 
activity, mediating anti-tumour and anti-viral responses[128]. Depletion of NK cells substantially 
encourages CRC development, whereas increased NK cell tumour infiltration is associated with a 
better prognosis, demonstrating the importance of these cells in mitigating tumour progression[129]. 
In two colitis-associated CRC mouse models, AOM/DSS and ApcMin/+/DSS which have a depletion of NK 
cells in adenomas, a diet supplemented with 5% BRB powder suppressed colon polyp size and 
frequency whilst enhancing NK cell tumour infiltration[130]. Moreover, in colon biopsies from CRC 
patients treated with oral BRB slurry, BRBs were shown to increase NK cell tumour infiltration[130]. 
In addition to NK lymphocytes, another immune cell population that has important immune 
surveillance roles are T cell lymphocytes. Cytotoxic killer, CD8+, T cells are involved in immune-
mediated cell death and can also act as cytokines, CD4+ T cells, known as helper T cells, secrete 
cytokines to assist with the immune response, and regulatory T cells mainly act to suppress T cell-
mediated immune response. In cancer T cells often become dysfunctional usually aiding cancer 
progression[131]. BRB-ethanol extract and two abundant BRB phytochemical metabolites (Cyanidin-
3-Rutinoside and Quercitin-3-Rutinoside) can modulate the proliferative capacity of the human CD4+ 
and CD8+ T lymphocytes. All compounds were able to inhibit activated-T cell proliferation and survival 
and reduced differentiation of myeloid-derived suppressor cells (MDSC, cells capable of priming the 
metastatic niche) in vitro, through modulation of the JAK/STAT pathway which has documented roles 
in MDSC differentiation. Prior studies have shown that the BRB phytochemicals, Cyanidin-3-glucoside 
anthocyanin, Quercetin and Rutin can inhibit JAK/STAT and MAPK signalling[132, 133].  The beneficial 
effects of BRBs on inflammation are diverse and numerous, in vitro, the anthocyanin component of 
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BRBs has been more effective at suppressing inflammation than the commonly used anti-
inflammatory drug 5-aminosalicylic acid[134], demonstrating how BRB and their metabolites can be 
an effective and accessible drug option for treatment of inflammation and inflammation-associated 
cancer.
2. Conclusion
The potential of BRBs as a cancer therapeutic is indisputable, as daily administration of BRBs 
have shown to reduce colorectal tumour/ polyp numbers, oral SCCs and severity in humans with 
minimal adverse effects[45, 74, 77]. Extensive research has revealed that BRBs have pleiotropic effects 
against all stages of carcinogenesis by promoting apoptosis and differentiation, reducing proliferation, 
modulating the epigenome, the microbiome and the metabolome, reducing tumour-mediated 
inflammation and oxidative stress and inhibiting angiogenesis (Figure 3). Collectively, these studies 
support the potential of BRBs for therapeutic cancer intervention and highlight the ability of BRBs to 
limit the window of opportunity of cancer initiation and progression. However, they highlight the 
complexity of the involvement of endogenous factors in carcinogenesis and emphasises the 
importance of understanding the precise mechanism in which dietary and drug interventions protect 
against cancer. Moreover, translation into the clinic has not been straightforward, with varied 
responses occurring among patients[74, 77]. This is likely to reflect inter- and intra-individual and 
tumoural heterogeneity, differences in molecular signalling and enzyme activity within tumours and 
variances in individuals’ microbiota and metabolism. In addition, the limited bioavailability of 
anthocyanins, the concentration, frequency, duration, delivery method and delivery matrix of BRB 
interventions has differed across studies, which could also be a confounding factor for reporting 
beneficial outcomes. BRBs have been administered as a slurry of freeze-dried powder suspended in 
water, as rectal suppositories, as topical agents delivered in a bioadhesive gel, or as dissolvable slow-
release BRB troches. It is important to note that the concept of chemoprevention is not to radicalise 
our lifestyle, but to identify ways in which to adopt a healthier lifestyle and reduce the window of 
opportunity of cancer development by lessening the risks. Patient compliance is often a rate limiting 
step in the success of chemopreventative strategies, and so it is important that such strategies are 
easy to adhere to. While it remains difficult to accurately estimate the concentration of BRB 
consumption for individual patients to have beneficial effects, it is necessary that the regime is simple 
and does not require the consumption of hundreds of berries a day which would not be a sustainable 
lifestyle change. It is also likely that for each given cancer type and predisposing disease that a specific 
BRB dose, delivery method and regime is utilised to maximise the efficacy of the treatment. 
It is also important to note that the chemopreventative effects of BRBs are not attributed to 
a single BRB compound but collectively from anthocyanins, ellagic acid, flavonoids, fibre, other 
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antioxidants and phytochemicals such as quercetin and rutin, and BRB metabolites which may 
individually impact on specific cellular processes, or work collectively to dampen down signalling 
pathways and prevent feedback loops and cross-talk among pathways that are fundamental for 
tumour development. Additionally, edible berries have proven to protect against cancer before the 
transformation of a premalignant cell, by aiding in the maintenance of a healthy body weight and 
supporting the growth and abundance of beneficial gut microbes that protect against diseases which 
predispose individuals to cancer such as obesity, diabetes, gastroesophageal reflux and inflammatory 
bowel diseases.
The best documented anti-cancer effects of BRBs have been identified in oral, oesophageal 
and colorectal cancers, it is clear that cancer can act systemically affecting the function of other organs 
and resulting in metastasis.  While research has started to focus on investigating the 
chemopreventative roles of BRBS in breast[135] and prostate cancer[136], future studies should focus 
on the impact of BRBs and their metabolites on 1) the systemic implications of cancer, 2) the ability of 
polyphenols to prevent metastasis at secondary sites, 3) the impact of BRBs on liver-intestinal cross 
talk due to the roles of the liver in metabolism and ultimately 4) the impact of BRB polyphenols on 
cancer stem cell or stem-cell like populations.
3. Figure Captions
Figure 1: Endogenous and Exogenous Risk Factors of Cancer Development
Cancer arises from abnormal and uncontrolled cell division. Cancer progression is the result of a 
complex interaction between innate host factors (endogenous risk factors), such as inherited 
mutations and epigenetic signatures, disturbances in microbial diversity due to chronic inflammatory 
diseases and reduce immune function, with exogenous factors that can increase mutational risk over 
time such as UV exposure, smoking, physical inactivity, obesity, inadequate dietary intake and alcohol 
consumption.
Figure 2: Overview of Black Raspberry Metabolism
Schematic representation of the organs involved in the absorption and metabolism of black raspberry 
polyphenols. 
Figure 3: Summary of the Cellular Processes Involved in BRB-Mediated CRC Chemoprevention
Black raspberries exert chemopreventative and therapeutic effects against colorectal cancer by acting 
on several cellular functions, biological processes and signalling pathways that are all interlinked. The 
protective effects of black raspberry arises from a complex interaction and cross-talk of BRB 
polyphenols on genes and proteins associated with epigenetics, inflammation, oxidative stress, 
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proliferation, cell cycle regulation, apoptosis, angiogenesis, metastasis and via modulation of the gut 
microbiome. So far little is known about the involvement of the intestinal stem cell compartment in 
BRB-mediated cancer prevention. Ͱ = Inhibition; ↓ = Decrease, ↑= Increase
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